Canwell Biotech Limited
Canwell Biotech Limited
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CW-301 FIH Study of CAN016 | Patients With Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-07-01 | NCT07664150 | |
| Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid Tumors | Solid Tumor | Active, not recruiting | Phase 1 | 2025-02-13 | NCT05580991 | |
| Intratumoral CAN2109 in Subjects With Solid Tumors | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2024-12-19 | NCT06332430 |